PORTAGEBIOTECH.COM: Keyword Density Checker

Total words: 1259 | 2-word phrases: 328 | 3-word phrases: 353 | 4-word phrases: 364

PAGE INFO

Title	Try to keep the title under 60 characters (22 characters) Home - Portage Biotech
Description	Try to keep the meta description between 50 - 160 characters (150 characters) Portage is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	portage biotech	9	2.74%
2	and a	5	1.52%
3	biotech inc	4	1.22%
4	asset combinations	3	0.91%
5	and asset	3	0.91%
6	our team	3	0.91%
7	assets and	3	0.91%
8	drug platforms	3	0.91%
9	resistance pathways	3	0.91%
10	known checkpoint	2	0.61%
11	pathways to	2	0.61%
12	financialregulatory reports	2	0.61%
13	corporate governance	2	0.61%
14	governance investor	2	0.61%
15	investor faqs	2	0.61%
16	faqs join	2	0.61%
17	team contact	2	0.61%
18	quality of	2	0.61%
19	our portfolio	2	0.61%
20	of life	2	0.61%

#	Keyword	Frequency	Density
1	portage biotech inc	4	1.13%
2	and asset combinations	3	0.85%
3	assets and asset	3	0.85%
4	other programs in	2	0.57%
5	quality of life	2	0.57%
6	our team contact	2	0.57%
7	resistance pathways to	2	0.57%
8	investor faqs join	2	0.57%
9	governance investor faqs	2	0.57%
10	corporate governance investor	2	0.57%
11	presentationspublications sec filings	2	0.57%
12	news releases investor	2	0.57%
13	overview stock information	2	0.57%
14	diverse drug platforms	2	0.57%
15	in development investors	2	0.57%
16	programs in development	2	0.57%
17	releases investor calendar	2	0.57%
18	us overview leadership	2	0.57%
19	platform adenosine platform	2	0.57%
20	our pipeline inkt	2	0.57%
21	leadership our pipeline	2	0.57%
22	overview leadership our	2	0.57%
23	immunotherapy assets and	1	0.28%
24	oncology drug approvals	1	0.28%
25	human proof of	1	0.28%
26	from bench through	1	0.28%
27	combinations from bench	1	0.28%
28	asset combinations from	1	0.28%
29	counsel to guide	1	0.28%
30	novel immunotherapy assets	1	0.28%

#	Keyword	Frequency	Density
1	assets and asset combinations	3	0.82%
2	corporate governance investor faqs	2	0.55%
3	programs in development investors	2	0.55%
4	other programs in development	2	0.55%
5	leadership our pipeline inkt	2	0.55%
6	overview leadership our pipeline	2	0.55%
7	us overview leadership our	2	0.55%
8	news releases investor calendar	2	0.55%
9	governance investor faqs join	2	0.55%
10	company growth portage actively	1	0.27%
11	and company growth portage	1	0.27%
12	potential and company growth	1	0.27%
13	strategic counsel to guide	1	0.27%
14	growth portage actively engages	1	0.27%
15	portage actively engages in	1	0.27%
16	the drug development process	1	0.27%
17	drug development process and	1	0.27%
18	development process and provides	1	0.27%
19	commercial potential and company	1	0.27%
20	development strategy that supports	1	0.27%
21	process and provides strategic	1	0.27%
22	and provides strategic counsel	1	0.27%
23	provides strategic counsel to	1	0.27%
24	skip to content portage	1	0.27%
25	asset combinations from bench	1	0.27%
26	novel immunotherapy assets and	1	0.27%
27	team of scientists clinicians	1	0.27%
28	long history of success	1	0.27%
29	a long history of	1	0.27%
30	have a long history	1	0.27%
31	executives have a long	1	0.27%
32	pharmaexperienced executives have a	1	0.27%
33	of scientists clinicians and	1	0.27%
34	our team of scientists	1	0.27%
35	immunotherapy assets and asset	1	0.27%
36	concept our team of	1	0.27%
37	of concept our team	1	0.27%
38	proof of concept our	1	0.27%
39	human proof of concept	1	0.27%
40	combinations from bench through	1	0.27%